3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
52
Thoracic
33
Breast
33
Genitourinary
25
Gynecologic
24
CNS
19
Tumor-Agnostic
17
Head & Neck
17
Lymphoid
16
Sarcoma
13
Other hematologic neoplasm
11
Dermatologic
10
Myeloid
6
Plasma cell
5
Other solid neoplasm
3
Endocrine
2
NET
1
Classical hematology
1
Conditions
Polycystic Kidney, Autosomal Recessive
1
Neurofibromatosis-Noonan syndrome
1
Neurofibromatoses
1
Myotonic Dystrophy
1
Muscular Dystrophy, Duchenne
1
Hydrocephalus, X-linked
1
Huntington Disease
1
Hemophilia B
1
Hemophilia A
1
Fragile X Syndrome
1
Cystic Fibrosis
1
Anemia, Sickle Cell
1
Interventions
Cyclophosphamide
11
fludarabine phosphate
8
fludarabine
8
apixaban
8
Mycophenolic Acid
6
Melphalan
6
Busulfan
6
Whole-Body Irradiation
4
Tacrolimus
4
Rivaroxaban
4
Filgrastim
4
Biopsy
4
thymoglobulin
3
X-Rays
3
Specimen Handling
3
Rituximab
3
Peripheral Blood Stem Cell Transplantation
3
Hematopoietic Stem Cell Transplantation
3
Granulocyte Colony-Stimulating Factor
3
Enoxaparin
3
Bone Marrow Transplantation
3
Azacitidine
3
venetoclax
2
pegylated granulocyte colony-stimulating factor
2
olaparib
2
Tretinoin
2
Stem Cell Transplantation
2
Mesna
2
Injections
2
Heparin, Low-Molecular-Weight
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Blood Specimen Collection
×
Classical hematology
×
Clear all
NCT06147414
2026-04-23
DANNIgene
Assistance Publique - Hôpitaux de Paris
Recruiting
550 enrolled